KMDA Q4 2020 Earnings — Kamada Ltd. Revenue & Financial Results | Market Cap Arena

KMDAKamada Ltd.

$495M

Q4 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$32M-1.6% YoY

Gross Profit

$10M32.2% margin

Operating Income

$3M8.4% margin

Net Income

$2M5.2% margin

EPS (Diluted)

$0.04

QoQ Revenue Growth

-10.7%

Cash Flow

Operating Cash Flow

$14M

Free Cash Flow

$11M

Stock-Based Comp.

$124,000

Balance Sheet

Total Assets

$211M

Total Liabilities

$32M

Stockholders' Equity

$179M

Cash & Equivalents

$70M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$32M	$32M	-1.6%
Gross Profit	$10M	$12M	-15.9%
Operating Income	$3M	$5M	-51.7%
Net Income	$2M	$5M	-69.6%